Vitrectomy Devices Market
Report ID: SQMIG35A3765
Report ID: SQMIG35A3765
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A3765 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
95
|Figures:
76
Global Vitrectomy Devices Market size was valued at USD 6.1 Billion in 2024 and is poised to grow from USD 6.55 Billion in 2025 to USD 11.5 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).
The main factor driving the vitrectomy device market growth is the increasing burden of retinal diseases with innovative technology. These advances in technology have changed how retinal diseases are treated, which has created a higher demand for vitrectomy devices. Vitrectomy devices are surgical equipment that allows the surgeon to remove the vitreous gel from the eye to help treat such retinal diseases as diabetic retinopathy, macular holes, and retinal detachments. Restoring vision and preventing blindness due to retinal diseases also has social and economic implications. The progression of vitrectomy devices has focused on transitioning from large bulky 20 gauge systems to the new miniaturized 23, 25, and 27 gauge microincisional systems. Innovators have also created some devices that have improved outcomes and safety; for example, high speed cutters, integrated endoillumination, and Intraoperative OCT (optical coherence tomography) to assist the surgeon in visualizing the retina.
These innovations have created less operating time per surgery leading to more successful outcomes which encourage the adoption of these devices. The combination of demographics and opportunities for the market to offer more efficient procedural standards creates an opportunity for both the device manufacturer’s and the providers of services offering vitrectomy to develop their market. As diabetes and the aging population increase the incidence of retinal disease, hospitals and ambulatory surgery centers are increased to more surgical cases creating an opportunity for them to prepare for adding devices that can provide smaller gauge platforms that reduce complication rates, as well as the time required for the procedure. Therefore, Vitrectomy surgeons are continuing to adopt the 25 and 27 gauge platforms to repair macular holes and diabetically tractional retinal detachments and provide same day discharge as well as increased surgical throughput. This shift generates demand for integrated visualization, disposable cutters and consumables, producing recurring revenue streams while improving access in emerging markets.
How is AI Improving Surgical Precision In The Vitrectomy Devices Market?
Vitrectomy equipment performance has been positively impacted by the introduction of artificial intelligence. This new technology is being implemented in the following ways: smarter imaging, real-time instrument location monitoring, motion compensation, and adaptive fluid flow. Incorporating these new capabilities will allow surgeons to see better during the procedure and to manipulate very delicate tissue while minimizing unintentional movement. Today, Vitrectomy equipment manufacturers are adding AI capabilities to the visual imaging system (visualization) and software-based fluid flow (fluidics) to assist surgeons with clinical decision-making and improve workflow speed. The market is requesting new versions of the vitrectomy equipment that improve predictability and reproducibility for surgeons who perform vitreoretinal (VR) procedures. An example would be head-up displays, intelligent fluidics, and motion compensating systems.
Together all of these technologies will help establish “how” to perform the procedure and improve intraoperative control. In April 2026, Bausch + Lomb received FDA approval for the company’s next-generation vitrectomy cutter and fluidics upgrade. This example of a new generation of surgical platform is evidence that surgical equipment and overall surgical processes are advancing towards providing surgeons with more intelligent control and more data-driven assistance. Additional improvements to AI-assisted imaging will provide surgeons with a better ability to generate steady cuts and control their movements throughout the surgical procedure while supporting continued surgeon adoption of speed and efficiency.
Market snapshot - (2026-2033)
Global Market Size
USD 6.1 Billion
Largest Segment
Vitrectomy Machines
Fastest Growth
Vitrectomy Packs
Growth Rate
7.3% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global vitrectomy devices market is segmented by product, application, end-user and region. Based on product, the market is segmented into Vitrectomy Machines, Vitrectomy Packs, Photocoagulation Lasers, Illumination Devices and Others. Based on application, the market is segmented into Diabetic Retinopathy, Retinal Detachment, Macular Hole, Vitreous Hemorrhage and Others. Based on end-user, the market is segmented into Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per vitrectomy devices market analysis, Conventional Vitrectomy Machines are the “core” of the posterior compartment eye surgeries. These machines combine the functions of cutting, fluid irrigation, illumination and pedicle control that allows the surgeon to perform many difficult and/or complex tasks to accomplish their surgical goals. In addition, the performance capabilities of modern vitrectomy devices and their ability to accommodate multiple modular platforms encourages the surgeon to prefer vitrectomy equipment manufactured by a particular supplier. Supplier investment in software capabilities, maintenance and compatibility of the various systems will continue to foster further investment by suppliers in the new technology, thus creating a continued cycle of product improvements and ultimately driving demand in the marketplace.
As per vitrectomy devices market forecast, disposable vitrectomy packs are the fastest growing segment because they provide convenience for single uses, aid in infection control and have standardized instrument sets, which simplifies operating room workflow. The increased clinician demand for ready-to-use sterile kits and increased regulatory emphasis on the sterility of surgical equipment has increased the sales of recurring consumables and the need for ongoing product innovation in the design and delivery of disposable vitrectomy packs.
Diabetes mellitus retinopathy procedure increase demand because of the increased utilization of posterior segment surgery-related vitrectomy surgical equipment to perform complicated posterior segment procedures; the complexity of diseases and variation in surgical procedures prolong the use of advanced cutting devices, illuminating devices, and intraoperative laser surgical devices, leading to continual updates to existing products and widespread procurement of new devices and products by surgical facilities needing assistance with these complex surgical procedures. As a result, the development of surgical products will continue to be focused on creating integrated products used for retinal surgical procedures as well as producing consumable materials associated with those products, thus maintaining the number one position within the market place.
As per vitrectomy devices market outlook, Retinal Detachment continues to be the fastest-growing segment of retinal surgical instruments due primarily to the innovative technology enabling surgeons to perform minimally invasive surgical procedures with improved overall patient outcomes and to increase the number of patients requiring surgical intervention. The increased utilization of small gauge vitrectomy and the increasing use of tamponade devices during surgical procedures creates a demand for specific products and instruments that can be utilized in conjunction with the devices and products used for performing the surgical procedure, which will encourage manufacturers to concentrate more on the development of specific instruments and devices for use by surgeons then on other product lines.
To get detailed segments analysis, Request a Free Sample Report
The North America has a strong hold on the overall vitrectomy devices marketplace due to its combination of advanced clinical infrastructure, a large concentration of innovative products, and supportive regulations that allow for the use of new surgical technologies within each country's healthcare system. A high number of medical device manufacturers, combined with the active development of clinical research, drive the pace at which new products are developed. When combined with high patient volumes being treated at specialized eye centers and available training programs for vitreoretinal surgeons, new instruments and/or platforms are rapidly being adopted by clinicians. Additionally, coordination between regulatory agencies and collaboration between industry and clinical stakeholders hastens the commercialization process of new therapeutic agents. Through the use of consolidated procurement initiatives, professional associations promote the standardization and dissemination of procedure-specific best practices within their respective markets. Finally, the significant amount of funding provided by private equity firms for the establishment or acquisition of surgical platforms supports a continuous volume of differentiated products. The increasing patient awareness of the need for better quality of vision will continue to enhance commercial adoption and collaboration among payers, providers, and manufacturers of surgical devices.
U.S. Vitrectomy Device Market is supported by a well developed array of tertiary eye care centers, large groups of expert providers in vitrectomy, and proximity to leading manufacturers of vitreous surgical instruments; therefore, clinical evaluations can occur quickly with an ongoing cycle of refinement for the product. There are multiple institutions using the latest systems for vitrectomy and offering comprehensive programs for education related to the use of these surgical systems and as well, a high level of involvement between the manufacturers and the leading surgeons from a collaborative model exists to guide improvements and enhancements to make the surgical instruments and the evidence generated from these instructors available in order to develop guidelines for procurement and clinical practice.
Canada Vitrectomy Device Market key element is the presence of specialty eye clinics (centres of excellence) that create an encouraging environment to adopt refined vitrectomy platforms and accessories. The coordinated delivery of care among clinicians, the emphasis on providing multi-disciplinary care, and the ongoing development of standards for performing surgeries, all work together to support a user-friendly vitrectomy system. The experience of a number of clinicians and hospitals working closely with the manufacturers provide local professionals with immediate access to new technology. Consequently, innovation in the industry can often occur through the integration of new devices into the provision of vitrectomy as part of the existing continuum of care, while continuing to develop a body of evidence regarding the new instruments and their associated surgical techniques.
Rapid expansion of the vitrectomy devices market in Europe is driven by an aligned ecosystem of clinical excellence, centralized health technology assessment processes, and proactive investment in minimally invasive surgical approaches. A competitive manufacturing base and strong collaborative networks among academic centers, clinical opinion leaders, and industry accelerate localized innovation and product adaptation for diverse care settings. Regulatory harmonization and reimbursement engagement facilitate broader market access, while focused professional education and regional centers of competence support dissemination of advanced techniques. Patient centred care initiatives and emphasis on outcome optimization further motivate adoption, prompting suppliers to tailor device configurations and service models to meet evolving clinical and procurement preferences across varied national health systems. Cross border clinical collaborations and regional procurement consortia encourage shared learning and scale for new platforms, while suppliers emphasize post market support and modular device design to address heterogeneous surgical practices.
Vitrectomy Devices Market in Germany benefits from a strong industrial base, network of specialized clinics, and clinical evaluation pathways that favor evidence adoption. Close collaboration between manufacturers and university hospitals supports tailored surgical platforms and procurement that enable deployment across hospital systems. Emphasis on training and clinical research fosters iterative refinement of devices and techniques, reinforcing Germany position as a leading adopter and center of innovation within the regional market.
Vitrectomy Devices Market in United Kingdom is characterized by adoption driven by active clinical research networks, strong academic hospital engagement, and a competitive supplier environment that prioritizes modular, friendly platforms. A mix of public and private care settings fosters diverse adoption pathways and validation of new technologies. Focused investment in surgeon training and multidisciplinary care models accelerates clinical acceptance, positioning United Kingdom as a growth market within Europe with commercialization.
Vitrectomy Devices Market in France is driven by strong hospital networks, active clinical research in ophthalmology, and growing collaboration with device innovators. National focus on improving surgical outcomes and integrated care pathways encourages selective adoption of minimally invasive platforms. Suppliers engage regional centers to validate device usability and support training, while tailored service offerings help overcome procurement complexity and enable more integration of advanced vitrectomy technologies into routine surgical practice.
Asia Pacific is strengthening its position in the vitrectomy devices market through strategic enhancement of clinical capabilities, localized manufacturing, and targeted partnerships that adapt technologies to regional practice patterns. Investment in specialist training programs and centers of excellence raises surgical expertise, while growing clinical research activity supports evidence generation relevant to local patient populations. Manufacturers increasingly pursue joint ventures and localized production to improve supply chain resilience and cost competitiveness, complemented by aftermarket service networks that support device uptime. Regional market entrants and global suppliers both pursue modular, scalable platforms suited to diverse hospital settings, enabling more widespread adoption and reinforcing Asia Pacific role as an increasingly important innovation and demand center. Targeted regulatory coordination in key markets and pilot reimbursement initiatives lower entry hurdles, while academic collaborations produce localized evidence and training that accelerate clinical adoption across varied care settings.
Vitrectomy Devices Market in Japan is supported by a mature medical device ecosystem, strong clinical research institutions, and emphasis on surgical techniques that favor adoption of advanced vitrectomy platforms. Domestic manufacturers collaborate closely with clinicians to refine ergonomics and functionality, while robust after sales service and clinical training networks sustain utilization. Procurement practices and hospital networks facilitate piloting of new systems, enabling steady integration of innovations into routine ophthalmic care.
Vitrectomy Devices Market in South Korea advances through local manufacturing strength, adoption pathways, and focused clinical training that support uptake of sophisticated vitrectomy systems. Collaborative partnerships between device developers and tertiary hospitals enable usability testing and clinician feedback loops. Emphasis on compact, cost conscious device designs and strong service networks aligns offerings with hospital procurement priorities, enabling progressive incorporation of advanced instruments into local academic and community ophthalmic surgical settings.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Advances In Surgical Instrumentation
Expansion Of Minimally Invasive Techniques
High Procedure Costs and Reimbursement
Limited Skilled Surgeon Availability
Request Free Customization of this report to help us to meet your business objectives.
Competition in the global vitrectomy devices market is shaped by rapid technology innovation, clinical validation, and strategic consolidation. Established OEMs and deep tech entrants use acquisitions, hospital and research partnerships, and venture financing to capture surgical platform capabilities and clinical footholds. Notable moves include Carl Zeiss Meditec acquiring Preceyes, AcuSurgical completing clinical vitrectomy cases with its Luca robot, and ForSight Robotics securing late stage financing.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global vitrectomy devices market is being driven primarily by the rising burden of retinal disease coupled with rapid technological innovation, while a second driver is the shift toward minimally invasive techniques and procedural efficiency that enable higher throughput and ambulatory care. Growth is tempered by high procedure costs and reimbursement constraints that limit access and device adoption in some settings. North America remains the dominating region due to advanced clinical infrastructure and strong manufacturer presence. The Vitrectomy Machines segment is the dominating product category because it integrates cutting, fluidics and visualization that anchor surgical workflows. Market momentum favors integrated, disposable and AI‑enabled solutions.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 6.1 Billion |
| Market size value in 2033 | USD 11.5 Billion |
| Growth Rate | 7.3% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Vitrectomy Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Vitrectomy Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Vitrectomy Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Vitrectomy Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Vitrectomy Devices Market size was valued at USD 6.1 Billion in 2024 and is poised to grow from USD 6.55 Billion in 2025 to USD 11.5 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).
Competition in the global vitrectomy devices market is shaped by rapid technology innovation, clinical validation, and strategic consolidation. Established OEMs and deep tech entrants use acquisitions, hospital and research partnerships, and venture financing to capture surgical platform capabilities and clinical footholds. Notable moves include Carl Zeiss Meditec acquiring Preceyes, AcuSurgical completing clinical vitrectomy cases with its Luca robot, and ForSight Robotics securing late stage financing. 'Alcon', 'Bausch + Lomb', 'Carl Zeiss Meditec', 'Johnson & Johnson', 'Dorc International', 'Nidek', 'Topcon Corporation', 'Iridex Corporation', 'Peregrine Surgical', 'Geuder AG', 'D.O.R.C.', 'Oculus Optikgeräte', 'Hoya Corporation', 'BVI Medical', 'Santen Pharmaceutical', 'Insight Instruments', 'Fritz Ruck', 'Rumex International', 'Synergetics', 'Alimera Sciences'
Advances in instrumentation, such as smaller-gauge cutters, enhanced illumination, and improved fluidics, reduce intraoperative trauma and broaden the range of treatable vitreoretinal conditions, which encourages clinicians to adopt vitrectomy procedures more readily. By enabling more predictable outcomes and shorter procedure times, these technological improvements make vitrectomy a preferable option for a wider patient population and foster greater confidence among surgeons and healthcare facilities to invest in relevant devices and training, thereby supporting sustained market expansion and uptake and promoting collaborative care pathways.
Technological Miniaturization And Integration: Continuous advances in instrument miniaturization, integrated imaging, and fluidics are enabling less invasive vitrectomy procedures with improved precision and workflow efficiency. Device manufacturers are converging optics, software and ergonomics to deliver platforms that streamline intraoperative decision-making and reduce procedure complexity. This trend fosters collaboration across medtech, imaging and IT companies, accelerates adoption of next‑generation systems in diverse clinical settings, and shifts value toward integrated solutions offering seamless user experience, enhanced safety features, and simplified maintenance and training pathways.
Why does North America Dominate the Global Vitrectomy Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
